Déjà Vu: Unanswered Questions About Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection

Susan M Poutanen^{1

2

3}, Susy S Hota^{3

4}

Affiliations

¹ Department of Microbiology, University Health Network and Sinai Health, Toronto, Ontario, Canada.
² Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
³ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁴ Infection Prevention and Control Department, University Health Network, Toronto, Ontario, Canada.

Editorial

Susan M Poutanen et al. Clin Infect Dis. 2025.

. 2025 Feb 5;80(1):61-62.

doi: 10.1093/cid/ciae468.

Susan M Poutanen^{1

2

3}, Susy S Hota^{3

4}

¹ Department of Microbiology, University Health Network and Sinai Health, Toronto, Ontario, Canada.
² Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
³ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁴ Infection Prevention and Control Department, University Health Network, Toronto, Ontario, Canada.

No abstract available

Keywords: Clostridioides difficile infection; fecal microbiota transplantation; randomized controlled trial.

Comment on

A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection.
Drekonja DM, Shaukat A, Huang Y, Zhang JH, Reinink AR, Nugent S, Dominitz JA, Davis-Karim A, Gerding DN, Kyriakides TC. Drekonja DM, et al. Clin Infect Dis. 2025 Feb 5;80(1):52-60. doi: 10.1093/cid/ciae467. Clin Infect Dis. 2025. PMID: 39271107 Clinical Trial.